Physician profile
Phoebe Chen
NPI 1427639426
$1,167.70
in general payments reported to CMS, 2019-2025
13 companies · $981 in 2025
The $981 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $187 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $294.02 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $165.34 | 2025 | Oxervate |
| Bausch & Lomb Americas INC. | $160.96 | 2025 | Miebo, Xiidra |
| Glaukos Corporation | $132.33 | 2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Alcon Vision LLC | $123.06 | 2025 | Tryptyr |
| Amgen INC. | $72.81 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $52.65 | 2024-2025 | Tyrvaya |
| Coopervision INC. | $45.53 | 2024 | Onefit Contact Lens |
| Harrow Eye, LLC | $36.26 | 2025 | Vevye |
| Thea Pharma INC. | $24.50 | 2025 | Iyuzeh |
| Phathom Pharmaceuticals, INC. | $23.22 | 2024 | Voquezna |
| Sun Pharmaceutical Industries INC. | $21.89 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $15.13 | 2025 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phoebe Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.